Global (United States, European Union and China) Intraveno(IV) Iron Drugs Market Research Report 2019-2025


Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.
Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.
In 2019, the market size of Intraveno(IV) Iron Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intraveno(IV) Iron Drugs. 

This report studies the global market size of Intraveno(IV) Iron Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). 
This study presents the Intraveno(IV) Iron Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. 
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
    Allergan
    AMAG Pharmaceuticals
    Galenica
    Actavis
    American Regent
    Sanofi
    Luitpold Pharmaceuticals
    Fresenius Medical Care
    Pharmacosmos
    Vifor Pharma

Market Segment by Product Type
    Low Molecular Weight Iron Dextran
    Ferric Gluconate
    Iron Sucrose
    Ferric Carboxyl Maltose

Market Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

Key Regions split in this report: breakdown data for each region.
    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
    To analyze and research the Intraveno(IV) Iron Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Intraveno(IV) Iron Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications 
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Intraveno(IV) Iron Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
Global (United States, European Union and China) Intraveno(IV) Iron Drugs Market Research Report 2019-2025.pdf

Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Major Manufacturers Covered in This Report 1.3 Market Segment by Type 1.3.1 Global Intraveno(IV) Iron Drugs Market Size Growth Rate by Type (2019-2025) 1.3.2 Low Molecular Weight Iron Dextran 1.3.3 Ferric Gluconate 1.3.4 Iron Sucrose 1.3.5 Ferric Carboxyl Maltose 1.4 Market Segment by Application 1.4.1 Global Intraveno(IV) Iron Drugs Market Share by Application (2019-2025) 1.4.2 Hospitals 1.4.3 Ambulatory Surgical Centers 1.4.4 Diagnostic Centers 1.5 Study Objectives 1.6 Years Considered 2 Global Growth Trends 2.1 Global Intraveno(IV) Iron Drugs Market Size 2.1.1 Global Intraveno(IV) Iron Drugs Revenue 2014-2025 2.1.2 Global Intraveno(IV) Iron Drugs Sales 2014-2025 2.2 Intraveno(IV) Iron Drugs Growth Rate by Regions 2.2.1 Global Intraveno(IV) Iron Drugs Sales by Regions 2014-2019 2.2.2 Global Intraveno(IV) Iron Drugs Revenue by Regions 2014-2019 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 3 Market Share by Manufacturers 3.1 Intraveno(IV) Iron Drugs Sales by Manufacturers 3.1.1 Intraveno(IV) Iron Drugs Sales by Manufacturers 2014-2019 3.1.2 Intraveno(IV) Iron Drugs Sales Market Share by Manufacturers 2014-2019 3.2 Revenue by Manufacturers 3.2.1 Intraveno(IV) Iron Drugs Revenue by Manufacturers (2014-2019) 3.2.2 Intraveno(IV) Iron Drugs Revenue Share by Manufacturers (2014-2019) 3.2.3 Global Intraveno(IV) Iron Drugs Market Concentration Ratio (CR5 and HHI) 3.3 Intraveno(IV) Iron Drugs Price by Manufacturers 3.4 Key Manufacturers Intraveno(IV) Iron Drugs Plants/Factories Distribution and Area Served 3.5 Date of Key Manufacturers Enter into Intraveno(IV) Iron Drugs Market 3.6 Key Manufacturers Intraveno(IV) Iron Drugs Product Offered 3.7 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Sales and Revenue for Each Type 4.1.1 Low Molecular Weight Iron Dextran Sales and Revenue (2014-2019) 4.1.2 Ferric Gluconate Sales and Revenue (2014-2019) 4.1.3 Iron Sucrose Sales and Revenue (2014-2019) 4.1.4 Ferric Carboxyl Maltose Sales and Revenue (2014-2019) 4.2 Global Intraveno(IV) Iron Drugs Sales Market Share by Type 4.3 Global Intraveno(IV) Iron Drugs Revenue Market Share by Type 4.4 Intraveno(IV) Iron Drugs Price by Type 5 Market Size by Application 5.1 Overview 5.2 Global Intraveno(IV) Iron Drugs Sales by Application 6 United States 6.1 United States Intraveno(IV) Iron Drugs Breakdown Data by Company 6.2 United States Intraveno(IV) Iron Drugs Breakdown Data by Type 6.3 United States Intraveno(IV) Iron Drugs Breakdown Data by Application 7 European Union 7.1 European Union Intraveno(IV) Iron Drugs Breakdown Data by Company 7.2 European Union Intraveno(IV) Iron Drugs Breakdown Data by Type 7.3 European Union Intraveno(IV) Iron Drugs Breakdown Data by Application 8 China 8.1 China Intraveno(IV) Iron Drugs Breakdown Data by Company 8.2 China Intraveno(IV) Iron Drugs Breakdown Data by Type 8.3 China Intraveno(IV) Iron Drugs Breakdown Data by Application 9 Rest of World 9.1 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Company 9.2 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Type 9.3 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Application 9.4 Rest of World Intraveno(IV) Iron Drugs Breakdown Data by Countries 9.4.1 Rest of World Intraveno(IV) Iron Drugs Sales by Countries 9.4.2 Rest of World Intraveno(IV) Iron Drugs Revenue by Countries 9.4.3 Japan 9.4.4 Korea 9.4.5 India 9.4.6 Southeast Asia 10 Company Profiles 10.1 Allergan 10.1.1 Allergan Company Details 10.1.2 Company Description and Business Overview 10.1.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.1.4 Intraveno(IV) Iron Drugs Product Introduction 10.1.5 Allergan Recent Development 10.2 AMAG Pharmaceuticals 10.2.1 AMAG Pharmaceuticals Company Details 10.2.2 Company Description and Business Overview 10.2.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.2.4 Intraveno(IV) Iron Drugs Product Introduction 10.2.5 AMAG Pharmaceuticals Recent Development 10.3 Galenica 10.3.1 Galenica Company Details 10.3.2 Company Description and Business Overview 10.3.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.3.4 Intraveno(IV) Iron Drugs Product Introduction 10.3.5 Galenica Recent Development 10.4 Actavis 10.4.1 Actavis Company Details 10.4.2 Company Description and Business Overview 10.4.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.4.4 Intraveno(IV) Iron Drugs Product Introduction 10.4.5 Actavis Recent Development 10.5 American Regent 10.5.1 American Regent Company Details 10.5.2 Company Description and Business Overview 10.5.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.5.4 Intraveno(IV) Iron Drugs Product Introduction 10.5.5 American Regent Recent Development 10.6 Sanofi 10.6.1 Sanofi Company Details 10.6.2 Company Description and Business Overview 10.6.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.6.4 Intraveno(IV) Iron Drugs Product Introduction 10.6.5 Sanofi Recent Development 10.7 Luitpold Pharmaceuticals 10.7.1 Luitpold Pharmaceuticals Company Details 10.7.2 Company Description and Business Overview 10.7.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.7.4 Intraveno(IV) Iron Drugs Product Introduction 10.7.5 Luitpold Pharmaceuticals Recent Development 10.8 Fresenius Medical Care 10.8.1 Fresenius Medical Care Company Details 10.8.2 Company Description and Business Overview 10.8.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.8.4 Intraveno(IV) Iron Drugs Product Introduction 10.8.5 Fresenius Medical Care Recent Development 10.9 Pharmacosmos 10.9.1 Pharmacosmos Company Details 10.9.2 Company Description and Business Overview 10.9.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.9.4 Intraveno(IV) Iron Drugs Product Introduction 10.9.5 Pharmacosmos Recent Development 10.10 Vifor Pharma 10.10.1 Vifor Pharma Company Details 10.10.2 Company Description and Business Overview 10.10.3 Sales, Revenue and Market Share of Intraveno(IV) Iron Drugs 10.10.4 Intraveno(IV) Iron Drugs Product Introduction 10.10.5 Vifor Pharma Recent Development 11 Value Chain and Sales Channels Analysis 11.1 Value Chain Analysis 11.2 Sales Channels Analysis 11.2.1 Intraveno(IV) Iron Drugs Sales Channels 11.2.2 Intraveno(IV) Iron Drugs Distributors 11.3 Intraveno(IV) Iron Drugs Customers 12 Market Forecast 12.1 Global Intraveno(IV) Iron Drugs Sales and Revenue Forecast 2019-2025 12.2 Global Intraveno(IV) Iron Drugs Sales Forecast by Type 12.3 Global Intraveno(IV) Iron Drugs Sales Forecast by Application 12.4 Intraveno(IV) Iron Drugs Forecast by Regions 12.4.1 Global Intraveno(IV) Iron Drugs Sales Forecast by Regions 2019-2025 12.4.2 Global Intraveno(IV) Iron Drugs Revenue Forecast by Regions 2019-2025 12.5 United States Market Forecast 12.6 European Union Market Forecast 12.7 China Market Forecast 12.8 Rest of World 12.8.1 Japan 12.8.2 Korea 12.8.3 India 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Smart Projectors Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Summary A smart projector is a video projector with extra inputs, connectivity and a built-in computer that is used primarily for entertainment and presentations. Like a standard video projector, a smart projector takes input audio/visual signals ...

Global Capsule Smart Projectors Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Summary Capsule Smart Projector is becoming popular recently, such as Anker?s new Nebula entertainment brand officially launched its second portable projector this year at CES, and despite its shortcomings, it?s one of the most compelling new gadg...

Global Capsule Smart Mini Projectors Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Summary Capsule Smart Mini Projector is becoming popular recently, such as Anker?s new Nebula entertainment brand officially launched its second portable projector this year at CES, and despite its shortcomings, it?s one of the most compelling new...

Global Weighing Scale Indicators Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Summary Weighing indicator is used in weighing scale?for industrial weighing, checkweighing, dynamic weighing and counting tasks etc field. The global Weighing Scale Indicators market was xx million US$ in 2018 and is expected to xx million US$ b...

Global Weighing Indicators Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Summary Weighing indicator is used in weighing scale?for industrial weighing, checkweighing, dynamic weighing and counting tasks etc field. The global Weighing Indicators market was xx million US$ in 2018 and is expected to xx million US$ by the ...

New Pharmaceuticals and Healthcare Reports

Publisher: QY Research